Cell therapeutics platform

This platform with its enhanced GMP facilities for production of clinical-grade DC is established in Erlangen DE (P6, Schuler / Schuler-Thurner). However, later it was decided to seek a licence for the production of GMP-grade mRNA that will be used for the (revised) multi-centre clinical trial.

created over 15 years ago (16 April 2010)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]